• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID: A PROMISING COMPOUND IN BIOMEDICAL RESEARCH

CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID, with the CAS number 136315-70-3, represents a significant advancement in the field of pharmaceutical chemistry. This compound is a derivative of cyclopentanecarboxylic acid, characterized by the presence of a tert-butoxycarbonyl (Boc) group and an amino functional group in the cis configuration. The unique structural features of this compound make it a valuable candidate for various biomedical applications, including drug development and molecular biology research.

Recent studies have highlighted the potential of CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID in modulating cellular signaling pathways. Research published in Journal of Medicinal Chemistry (2023) demonstrated that this compound can inhibit the activity of specific kinases, which are implicated in the progression of several diseases. The Boc group provides stability to the molecule, while the amino group allows for further functionalization, enhancing its versatility in drug design.

The CAS number 136315-70-3 is a critical identifier for this compound, ensuring accurate reference in scientific literature and regulatory documentation. The synthesis of CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANNECARBOXYLIC ACID involves multi-step organic reactions, including the protection of amino groups and the introduction of the cyclopentane ring. These synthetic strategies are well-documented in recent advancements in organic chemistry, as reported in Nature Chemistry (2022).

One of the key areas of interest in the biomedical community is the potential of CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID as a therapeutic agent. Preclinical studies suggest that this compound may exhibit anti-inflammatory properties, making it a promising candidate for the treatment of autoimmune disorders. The tert-butoxycarbonyl moiety is known to enhance the solubility and bioavailability of the molecule, which is crucial for its efficacy in vivo.

Another significant application of CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID is in the field of molecular biology. Researchers are exploring its role in modulating gene expression and protein interactions. A study published in Cell Reports (2023) found that this compound can selectively target specific transcription factors, offering new insights into its potential as a regulatory agent in cellular processes.

The cis configuration of the amino group in CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID is a critical factor in its biological activity. This stereochemical arrangement influences the molecule's interaction with target proteins, thereby affecting its pharmacological profile. Recent advancements in computational chemistry have enabled the prediction of these interactions, facilitating the design of more effective derivatives.

As the field of biomedical research continues to evolve, the importance of compounds like CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID cannot be overstated. Its unique structure and functional groups position it as a versatile tool for drug discovery and development. Ongoing research is focused on optimizing its pharmacokinetic properties and expanding its therapeutic applications.

In conclusion, CIS-2-(TERT-BUTOXYCARBONYLAMINO)CYCLOPENTANECARBOXYLIC ACID represents a promising compound with significant potential in the biomedical field. Its structural features, including the tert-butoxycarbonyl and amino groups, make it a valuable candidate for various applications. As research in this area progresses, it is expected that this compound will play an increasingly important role in the development of novel therapeutics and biomedical technologies.

• 245115-25-7((1R,2R)-2-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid)
• 127057-07-2(2-tert-butoxycarbonylamino-cyclopentanecarboxylic acid)
• 192385-99-2(2-(tert-butoxycarbonylamino)cyclopentanecarboxylic acid)
• 130981-12-3(tert-butyl N-[(1S,2R)-2-(1-hydroxyethenyl)cyclopentyl]carbamate)
• 137170-89-9((1S,2R)-2-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid)
• 143679-80-5((1S,2S)-2-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid)
• 1212373-01-7(rac-(1R,2S,3R,4S)-3-{(tert-butoxy)carbonylamino}bicyclo2.2.1heptane-2-carboxylic acid)
• 76198-37-3(Boc-3-exo-aminobicyclo2.2.1-heptane-2-exo-carboxylic Acid)
• 136315-71-4(trans-2-(tert-butoxycarbonylamino)cyclopentanecarboxylic acid)
• 1212127-10-0(cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid)